Expressing the sense of Congress on the need to inform American consumers with more balanced purchasing information for prescription drugs through the disclosure of price information in direct-to-consumer (DTC) advertisements.

[AI summary unavailable — showing source text] This concurrent resolution expresses the sense of Congress that (1) the efficient administration of Medicare and Medicaid encompasses federal efforts to achieve good value for funds spent in those programs; (2) the Centers for Medicare & Medicaid Services (CMS) has the authority to require direct-to-consumer television advertisements of prescription drugs and biological products to include the drug or product's list price; (3) the final rule by the CMS published in the Federal Register on May 10, 2019, makes substantial progress in improving drug pricing transparency; and (4) such rule should be enacted into law.…